Cambridge Investment Research Advisors »

Atara Biotherapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $245k 17k 14.32

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
Marshall Wace
BlackRock
Mackenzie Financial
Geode Capital Management
Acadian Asset Management
Staley Capital Advisers
GSA Capital Partners
State Street Corporation
Jane Street
Renaissance Technologies
UBS Group
FMR

View all funds holding Atara Biotherapeutics